Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Oncotarget|May 3, 2018
Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinomaCaroline V M Verhagen, David M Vossen, Kerstin Borgmann, et al.
Nature Communications|February 4, 2018
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancerTesa M Severson, Yongsoo Kim, Stacey E P Joosten, et al.
Nature Communications|November 30, 2022
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potentialJeroen Kneppers, Tesa M Severson, Joseph C Siefert, et al.
Oncoimmunology|December 8, 2018
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survivalMarcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patientsTesa M Severson, Yanyun Zhu, Stefan Prekovic, et al.
Molecular Oncology|April 1, 2015
Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platformsPhilip C Schouten, Anita Grigoriadis, Thomas Kuilman, et al.
Nature Communications|January 25, 2020
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancerStanley Zhou, James R Hawley, Fraser Soares, et al.
Cell Reports. Medicine|July 3, 2025
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa M Severson, Emma Minnee, Yanyun Zhu, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Nature Genetics|January 19, 2010
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originRyan D Morin, Nathalie A Johnson, Tesa M Severson, et al.
Pageof 4